Give a consise short note on surviving sepsis guidelines for dnb anaesthesia exam

Reading File
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
Running Command
I now have comprehensive data from the full SSC 2026 guidelines. Let me write the concise exam-focused note.

Surviving Sepsis Campaign (SSC) 2026 Guidelines - Short Note for DNB Anaesthesia Exam

Source: SSC International Guidelines for Management of Sepsis and Septic Shock 2026 (Prescott HC et al. Critical Care Medicine, April 2026)

Definition (Sepsis-3)

  • Sepsis: Life-threatening acute organ dysfunction due to infection
  • Septic shock: Subset with circulatory dysfunction requiring vasopressors to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation (mortality >40%)

SCREENING & EARLY MANAGEMENT

#RecommendationStrength
1Performance improvement program with sepsis screening, SOPs, and QI strategiesStrong
2"Code sepsis" / sepsis huddle protocolConditional
3Prehospital ambulance screening toolConditional
4NEWS, NEWS2, MEWS, or SIRS over qSOFA as single screening toolStrong
5Sepsis is a clinical diagnosis - cannot rule in/out by single biomarkerGood practice
7Blood cultures before antibiotics (but don't delay antibiotics)Strong
8Measure blood lactateConditional
9Sepsis/septic shock = medical emergency, treat immediatelyGood practice

INITIAL RESUSCITATION

RecommendationDetailStrength
IV fluidsAt least 30 mL/kg crystalloid in first 3 hours (use IBW if BMI >30)Conditional
Vasopressor timingFluid bolus first, then vasopressor if hypotension persists. Concurrent if unstableConditional
Peripheral vasopressorsStart peripherally rather than delay for central accessConditional
MAP target65 mmHg (initial target for all); 60-65 mmHg for patients ≥65 yearsStrong / Conditional
ICU admissionWithin 6 hours for patients requiring ICUConditional

INFECTION MANAGEMENT

Antibiotic Timing:
  • Septic shock (possible/probable/definite): Antibiotics immediately, ideally within 1 hour - Strong
  • Probable/definite sepsis without shock: Antibiotics immediately, within 1 hour - Strong
  • Possible sepsis without shock: Rapid assessment; administer within 3 hours if infection likely - Conditional
  • Low likelihood of infection, no shock: Defer antibiotics, monitor closely - Conditional
Source control: Evaluate rapidly; perform within 6 hours of diagnosis - Conditional
Antibiotic Principles:
  • Prolonged infusion of beta-lactams (after loading dose) over bolus - Strong (high certainty - BLING III data)
  • De-escalation when microbiological diagnosis available - Strong
  • Shorter duration over longer duration (adequate source control) - Conditional
  • Procalcitonin + clinical evaluation to guide antibiotic discontinuation - Conditional
  • Empiric antifungal: suggest against routine use (consider in high-risk: immunosuppression, prolonged abx, intra-abdominal source) - Conditional
  • Empiric anaerobic coverage only with specific risk factors (intra-abdominal, necrotizing fasciitis, head-neck) - Conditional
  • SDD (selective decontamination of digestive tract) in mechanically ventilated patients in low-MDR resistance settings - Conditional

HEMODYNAMIC MANAGEMENT

Vasopressors:
  1. Norepinephrine (NE) = first-line vasopressor - Strong
  2. NE preferred over vasopressin, angiotensin II - Conditional
  3. Add vasopressin when escalating NE doses - Conditional (moderate evidence)
  4. Add epinephrine if inadequate MAP on NE + vasopressin - Conditional
  5. Septic shock + cardiac dysfunction: NE or epinephrine (either) - Conditional
  6. Terlipressin: suggest against - Conditional
  7. Methylene blue (refractory shock): insufficient evidence
Inotropes (cardiac dysfunction + persistent hypoperfusion):
  • Use inotropes - Conditional
  • Dobutamine + NE or epinephrine alone - Conditional
  • Levosimendan: suggest against - Conditional
Fluid Type:
  • Crystalloids = first-line - Strong
  • Balanced crystalloids (Ringer's) over 0.9% saline - Conditional (exception: TBI - use saline)
  • Albumin: suggest against routine use; consider in large crystalloid volumes or cirrhosis - Conditional
  • Starches: strongly against - Strong (high certainty)
  • Gelatins: suggest against - Conditional
Fluid Resuscitation After Initial 30 mL/kg:
  • Liberal vs restrictive: either, individualized - Conditional
  • Use dynamic measures (PPV, SVV, passive leg raise, stroke volume) to guide further fluids - Conditional
  • Serial lactate measurements to guide resuscitation - Conditional
  • Capillary refill time as adjunct to other perfusion measures - Conditional

RESPIRATORY SUPPORT

InterventionRecommendationStrength
Oxygen targetsTitrate FiO2; most use SpO2 90-96%Conditional
HFNC over conventional O2 (PaO2/FiO2 <200)Suggest HFNCConditional
HFNC over NIPPV as initial therapySuggest HFNCConditional
Awake proning (non-intubated)Suggest trialConditional
Low tidal volume 6 mL/kg IBW (ARDS)RecommendStrong (high certainty)
Non-ARDS mechanical ventilation6-8 mL/kg IBWConditional
Plateau pressure ≤30 cmH2O (ARDS)RecommendStrong
Higher PEEP (moderate-severe ARDS)SuggestConditional
Incremental PEEP titration strategyRecommend againstStrong
Prone ventilation >12 hr/day (moderate-severe ARDS)SuggestConditional
NMBA: intermittent bolus over continuous infusionSuggestConditional
VV-ECMO (severe ARDS, conventional MV fails)Suggest (experienced centers)Conditional

ADJUNCTIVE THERAPIES

DrugRecommendation
IV corticosteroids (septic shock)Suggest use - Conditional. Hydrocortisone 200 mg/day × 7 days
IV Vitamin CSuggest against
IV ImmunoglobulinSuggest against
Blood purification (hemoperfusion, plasmapheresis, high-dose HF)Suggest against
Polymyxin B hemoperfusionSuggest against
Vitamin DSuggest against (for sepsis treatment)
AntipyreticsSuggest against (for improving outcomes; OK for symptom relief)
ProbioticsSuggest against
Beta-blockersSuggest against

ADDITIONAL SUPPORTIVE CARE

InterventionRecommendationStrength
Stress ulcer prophylaxis (PPI) in those with GI bleed risk factorsSuggestConditional
Restrictive blood transfusionRecommendStrong
Early enteral nutrition (within 72 h)SuggestConditional
Insulin: initiate at glucose ≥180 mg/dL (10 mmol/L)RecommendStrong
RRT: against routine use without definitive indicationSuggest againstConditional
Continuous or intermittent RRT (when needed): eitherSuggestConditional
NaHCO3: against for hemodynamics/vasopressor reductionSuggest againstConditional
NaHCO3: use if pH ≤7.2 + AKI (AKIN 2-3)SuggestConditional
VTE prophylaxis with LMWH (unless contraindicated)RecommendStrong
Pharmacological VTE prophylaxis alone (over combined mechanical)SuggestConditional
Active fluid removal (post-acute resuscitation phase)SuggestConditional

GOALS OF CARE

  • Discuss goals of care with patient/family - Good practice
  • Address goals within 72 hours - Conditional
  • Principles of palliative care should be integrated when appropriate - Good practice
  • Against routine formal palliative care consultation for all - Conditional

KEY EXAM POINTS TO REMEMBER

  1. Hour-1 bundle: Blood cultures, lactate, 30 mL/kg fluids, broad-spectrum antibiotics, vasopressors if hypotensive
  2. Antibiotics: within 1 hour for septic shock; within 1 hour for probable/definite sepsis; within 3 hours for possible sepsis
  3. MAP target: 65 mmHg (initial). For age ≥65 years: 60-65 mmHg (new in 2026)
  4. Vasopressor order: NE → add vasopressin → add epinephrine
  5. Crystalloids first; balanced > normal saline; strongly against starches
  6. Prolonged beta-lactam infusion: strong recommendation (upgraded to strong in 2026 based on BLING III)
  7. Low tidal volume 6 mL/kg IBW for ARDS (strong, high certainty)
  8. Corticosteroids for septic shock: hydrocortisone 200 mg/day (conditional)
  9. Insulin: start at glucose ≥180 mg/dL
  10. LMWH for VTE prophylaxis (strong)
  11. NEWS/NEWS2/MEWS/SIRS preferred over qSOFA for in-hospital screening (strong - new in 2026)
  12. HFNC preferred over conventional O2 and NIPPV for acute hypoxemic respiratory failure (new in 2026)
  13. SDD: new conditional recommendation in low-MDR settings

Note: This note is based on the SSC 2026 Guidelines (April 2026, Critical Care Medicine), which is the most current version of the guidelines at the time of writing. Key changes from 2021 include: MAP 60-65 for elderly, NEWS over qSOFA made strong, prolonged beta-lactam infusion upgraded to strong, HFNC recommendations formalized, SDD added, and several new adjunctive therapy recommendations.
This is a shared conversation. Sign in to Orris to start your own chat.